首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >High-throughput, high-fidelity HLA genotyping with deep sequencing
【24h】

High-throughput, high-fidelity HLA genotyping with deep sequencing

机译:深度测序的高通量,高保真HLA基因分型

获取原文
获取原文并翻译 | 示例
       

摘要

Human leukocyte antigen (HLA) genes are the most polymorphic in the human genome. They play a pivotal role in the immune response and have been implicated in numerous human pathologies, especially autoimmunity and infectious diseases. Despite their importance, however, they are rarely characterized comprehensively because of the prohibitive cost of standard technologies and the technical challenges of accurately discriminating between these highly related genes and their many allelles. Here we demonstrate a high-resolution, and cost-effective methodology to type HLA genes by sequencing, which combines the advantage of long-range amplification, the power of high-throughput sequencing platforms, and a unique genotyping algorithm. We calibrated our method for HLA-A, -B, -C, and -DRB1 genes with both reference cell lines and clinical samples and identified several previously undescribed alleles with mismatches, insertions, and deletions. We have further demonstrated the utility of this method in a clinical setting by typing five clinical samples in an Illumina MiSeq instrument with a 5-d turnaround. Overall, this technology has the capacity to deliver low-cost, high-throughput, and accurate HLA typing by multiplexing thousands of samples in a single sequencing run, which will enable comprehensive disease-association studies with large cohorts. Furthermore, this approach can also be extended to include other polymorphic genes.
机译:人类白细胞抗原(HLA)基因是人类基因组中最多态的。它们在免疫应答中起关键作用,并与许多人类疾病有关,尤其是自身免疫和传染性疾病。尽管它们很重要,但是由于标准技术的昂贵成本以及准确地区分这些高度相关的基因及其许多等位基因的技术挑战,它们很少得到全面表征。在这里,我们展示了一种通过测序来分型HLA基因的高分辨率且经济高效的方法,该方法结合了远程扩增的优势,高通量测序平台的功能以及独特的基因分型算法。我们用参考细胞系和临床样品对HLA-A,-B,-C和-DRB1基因进行了校准,并鉴定了多个先前未描述的等位基因,它们具有错配,插入和缺失。通过在具有5-d周转的Illumina MiSeq仪器中键入五个临床样品,我们进一步证明了该方法在临床环境中的实用性。总体而言,该技术具有通过在一次测序运行中对数千个样品进行多路复用来提供低成本,高通量和准确的HLA分型的能力,这将使大型人群能够进行全面的疾病关联研究。此外,该方法也可以扩展到包括其他多态基因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号